These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 18471934)

  • 1. IGF binding protein alterations on periplaque oligodendrocytes in multiple sclerosis: implications for remyelination.
    Wilczak N; Chesik D; Hoekstra D; De Keyser J
    Neurochem Int; 2008 Jun; 52(8):1431-5. PubMed ID: 18471934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why does remyelination fail in multiple sclerosis?
    Franklin RJ
    Nat Rev Neurosci; 2002 Sep; 3(9):705-14. PubMed ID: 12209119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The insulin-like growth factor system in multiple sclerosis.
    Chesik D; Wilczak N; De Keyser J
    Int Rev Neurobiol; 2007; 79():203-26. PubMed ID: 17531843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions.
    Kuhlmann T; Lucchinetti C; Zettl UK; Bitsch A; Lassmann H; Brück W
    Glia; 1999 Oct; 28(1):34-9. PubMed ID: 10498820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of the extracellular matrix interferes with raft association of neurofascin in oligodendrocytes. Potential significance for multiple sclerosis?
    Maier O; van der Heide T; van Dam AM; Baron W; de Vries H; Hoekstra D
    Mol Cell Neurosci; 2005 Feb; 28(2):390-401. PubMed ID: 15691718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factors and binding proteins in multiple sclerosis plaques.
    Gveric D; Cuzner ML; Newcombe J
    Neuropathol Appl Neurobiol; 1999 Jun; 25(3):215-25. PubMed ID: 10417663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelin transcription factor 1 (Myt1) expression in demyelinated lesions of rodent and human CNS.
    Vana AC; Lucchinetti CF; Le TQ; Armstrong RC
    Glia; 2007 May; 55(7):687-97. PubMed ID: 17330875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions.
    Prineas JW; Kwon EE; Goldenberg PZ; Ilyas AA; Quarles RH; Benjamins JA; Sprinkle TJ
    Lab Invest; 1989 Nov; 61(5):489-503. PubMed ID: 2811298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in the oligodendrocyte lineage, myelin, and white matter in adult mice lacking the chemokine receptor CXCR2.
    Padovani-Claudio DA; Liu L; Ransohoff RM; Miller RH
    Glia; 2006 Oct; 54(5):471-83. PubMed ID: 16886211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemical observations on the distribution of myelin-associated glycoprotein and myelin basic protein in multiple sclerosis lesions.
    Itoyama Y; Sternberger NH; Webster HD; Quarles RH; Cohen SR; Richardson EP
    Ann Neurol; 1980 Feb; 7(2):167-77. PubMed ID: 6154440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligodendrocytes in the early course of multiple sclerosis.
    Brück W; Schmied M; Suchanek G; Brück Y; Breitschopf H; Poser S; Piddlesden S; Lassmann H
    Ann Neurol; 1994 Jan; 35(1):65-73. PubMed ID: 8285595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligodendroglial lineage cells express nuclear p57kip2 in multiple sclerosis lesions.
    Pfeifenbring S; Metz I; Kremer D; Küry P; Hartung HP; Brück W
    Glia; 2013 Aug; 61(8):1250-60. PubMed ID: 23828667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor binding proteins-1 and -2 differentially inhibit rat oligodendrocyte precursor cell survival and differentiation in vitro.
    Kühl NM; De Keyser J; De Vries H; Hoekstra D
    J Neurosci Res; 2002 Jul; 69(2):207-16. PubMed ID: 12111802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor binding protein-2 as a regulator of IGF actions in CNS: implications in multiple sclerosis.
    Chesik D; De Keyser J; Wilczak N
    Cytokine Growth Factor Rev; 2007; 18(3-4):267-78. PubMed ID: 17485236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion.
    Raine CS; Scheinberg L; Waltz JM
    Lab Invest; 1981 Dec; 45(6):534-46. PubMed ID: 7321526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis.
    Mastronardi FG; Moscarello MA
    J Neurosci Res; 2005 May; 80(3):301-8. PubMed ID: 15704220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of osteopontin and alphaBeta-crystallin in the normal-appearing white matter of multiple sclerosis: an immunohistochemical study utilizing tissue microarrays.
    Sinclair C; Mirakhur M; Kirk J; Farrell M; McQuaid S
    Neuropathol Appl Neurobiol; 2005 Jun; 31(3):292-303. PubMed ID: 15885066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor binding proteins: regulation in chronic active plaques in multiple sclerosis and functional analysis of glial cells.
    Chesik D; De Keyser J; Glazenburg L; Wilczak N
    Eur J Neurosci; 2006 Sep; 24(6):1645-52. PubMed ID: 17004928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis.
    Chang A; Tourtellotte WW; Rudick R; Trapp BD
    N Engl J Med; 2002 Jan; 346(3):165-73. PubMed ID: 11796850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remyelination capacity of the MS brain decreases with disease chronicity.
    Goldschmidt T; Antel J; König FB; Brück W; Kuhlmann T
    Neurology; 2009 Jun; 72(22):1914-21. PubMed ID: 19487649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.